End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 CNY | +3.10% | +3.85% | -28.60% |
08/04 | Lotus Health Group Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lotus Health to Buy 50% of Malaysian MSG Producer | MT |
Sales 2021 | 1.81B 250M 20.89B | Sales 2022 | 1.69B 233M 19.47B | Capitalization | 4.82B 666M 55.53B |
---|---|---|---|---|---|
Net income 2021 | 44M 6.07M 507M | Net income 2022 | 46M 6.35M 530M | EV / Sales 2021 | 2.32 x |
Net cash position 2021 | 1.19B 164M 13.71B | Net cash position 2022 | 1.35B 186M 15.49B | EV / Sales 2022 | 2.06 x |
P/E ratio 2021 |
100
x | P/E ratio 2022 |
90.3
x | Employees | 1,413 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.05% |
1 day | +3.10% | ||
1 week | +3.85% | ||
Current month | -8.47% | ||
1 month | -9.43% | ||
3 months | -6.29% | ||
6 months | -34.84% | ||
Current year | -28.60% |
Managers | Title | Age | Since |
---|---|---|---|
Tao Li
PSD | President | 52 | 10/22/10 |
Jia Sheng Cao
PSD | President | 40 | 01/20/01 |
Hou Wen Li
CHM | Chairman | 46 | 20/21/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mao Xin Chen
BRD | Director/Board Member | 68 | 19/20/19 |
Bin Li
BRD | Director/Board Member | 53 | 29/22/29 |
Yi Jun Wang
BRD | Director/Board Member | 55 | 26/22/26 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 4.32 | +3.10% | 63,046,100 |
25/24/25 | 4.19 | -1.41% | 37,737,400 |
24/24/24 | 4.25 | +2.91% | 48,686,630 |
23/24/23 | 4.13 | +0.49% | 30,727,200 |
22/24/22 | 4.11 | -1.20% | 34,029,800 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-28.60% | 1.06B | |
+2.35% | 29.77B | |
+4.50% | 21.6B | |
+13.39% | 11.83B | |
+12.40% | 5.15B | |
+11.10% | 4.21B | |
-16.49% | 3.48B | |
-3.84% | 3.14B | |
+4.73% | 3.11B | |
+27.19% | 2.79B |
- Stock Market
- Equities
- 600186 Stock